ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts
ABIVAX is a French biotech with a novel ulcerative colitis treatment in phase 3 trials. Click here to find out why I am ...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...
The Manila Times19h
Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy
Arialief offers a satisfaction guarantee, allowing customers to try the product risk-free. If users do not experience the ...
Le Lézard16h
InnoCare Releases 2024 Results and Business Highlights
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 annual results as of 31 December 2024. Financial ...
Prime Biome Gummies (EXPOSED): What Real Users Just Revealed About Prime Biome’S Gut & Skin Reset Formula
Discover how Prime Biome Gummies are transforming gut health and skin clarity-backed by real user experiences and science-backed ingredients.< ...
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck CancerConference call and webcast today ...
PDS Biotechnology Corporation: PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., March 27 ...
Alvotech Reports Record Results for 2024 and Provides Business Update
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, representing a 462% increase over prior yearAdjusted EBITDA in ...